Journal of Cancer Journal Abbreviation: J CANCER Journal ISSN: 1837-9664 YearImpact Factor (IF)Total ArticlesTotal Cites 2023 (2024 update)3.3-- 20223.9-14669 20214.478-14324 20204.20772511142 20193.5657326460 20183.1825363923 20173.2494552710 20162.9162701660...
Journal Abbreviation: J CANCER RES THER Journal ISSN: 0973-1482About Journal of Cancer Research and Therapeutics The Journal of Cancer Research and Therapeutics (JCRT), the official publication of Association of Radiation Oncologists of India (AROI). The JCRT, a quarterly publication, dedicated to...
Our journal websites will be undergoing scheduled maintenance this weekend. During this period, access to our journals may be disrupted. We apologise in advance for any inconvenience. >
Journal of Cancer is an open access, peer-reviewed journal with broad scope covering all areas of cancer research, especially novel concepts, new methods, new regimens, new therapeutic agents, and alternative approaches for early detection and intervention of cancer. 201120122013201420152016201720182019202020...
The Journal of Cancer Metastasis and Treatment, under the leadership of Executive Chief Editor Ciro Isidoro, is dedicated to the latest research on the etiology, mechanisms, and treatment of various cancers with a focus on metastasis. Research topics cov
5-year Journal Impact Factor 2.5 (2023) Submission to first decision (median) 6 days Downloads 571,045 (2024) Latest issue February 2025Volume 58, Issue 2 View all volumes and issues Latest articles Journal updates Call for Papers: Focus Issue on ‘Thrombosis in patients with cancer: challeng...
Stat Bite: Convergence of long-term trends in cervix uteri cancer incidence among Black and White women from 1975 to 2021 Nadia Howlader and others In 1975, the age-adjusted incidence of cervix uteri cancer was 28.0 cases per 100 000 (95% CI: 22.8 to 33.9) for Black women and 13.1 cases...
The 2024 edition of Journal Citation Reports® cites the 2023 journal impact factor (JIF) for WJCC as 1.0; JIF without journal self cites: 0.9; 5-year JIF: 1.1; JIF Rank: 170/329 in medicine, general and internal; JIF Quartile: Q3; and 5-year JIF Quartile: Q3. ISSN 2307-8960 (...
Dexmedetomidine with sufentanil in intravenous patient-controlled analgesia for relief from postoperative pain, inflammation and delirium after esophageal cancer surgery. Biosci Rep, 2020, 40(5): BSR20193410. 22. Xin J, Zhang Y, Zhou L, et al. Effect of dexmedetomidine infusion for intravenous ...
Explore breakthroughs in the Journal of Nanobiotechnology, with 10.6 Impact Factor and 4 days to first decision. Publishing at the cutting edge of ...